Anti-fibrotic potential of erythropoietin signaling on bone marrow derived fibrotic cell

INTRODUCTION: The number of patients with end stage kidney disease (ESKD) are increasing world-side. While interstitial fibrosis (IF) is a common step for the progression to ESKD, therapeutic options for IF is still limited in clinical settings. We have reported that bone marrow-derived fibrotic cel...

Descripción completa

Detalles Bibliográficos
Autores principales: Iwata, Yasunori, Sakai, Norihiko, Nakajima, Yuki, Oshima, Megumi, Nakagawa-Yoneda, Shiori, Ogura, Hisayuki, Sato, Koichi, Minami, Taichiro, Kitajima, Shinji, Toyama, Tadashi, Yamamura, Yuta, Miyagawa, Taro, Hara, Akinori, Shimizu, Miho, Furuichi, Kengo, Wada, Takashi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167964/
https://www.ncbi.nlm.nih.gov/pubmed/34059008
http://dx.doi.org/10.1186/s12882-021-02411-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8167964/
https://www.ncbi.nlm.nih.gov/pubmed/34059008
http://dx.doi.org/10.1186/s12882-021-02411-0

Ejemplares similares